• $5.5M grant awarded for spinal stem cell research

    The California Institute for Regenerative Medicine has awarded a $5.5 million grant to a University of California Irvine professor to study the use of stem cells to treat chronic cervical spinal cord injury.
  • 3 stem cell lawsuits making the news

    Over the past five years, the U.S. has seen a significant spike in the number of clinics advertising stem cell treatments, which claim to treat a range of orthopedic, neurological and autoimmune conditions, among others.
  • Regenerative implant for lumbar spine surgery gets FDA breakthrough designation

    Theradaptive's Osteo-Adapt SP spinal fusion implant received the FDA's breakthrough medical device designation, according to a Nov. 19 news release.
  • Pacira completes acquisition of Flexion Therapeutics

    Pacira Biosciences completed its acquisition of Flexion Therapeutics, according to a Nov. 19 news release.
  • Bioventus to bolster Tennessee presence, add 40 jobs

    Orthobiologics company Bioventus has signed a lease agreement to double its current operations and manufacturing space in Cordova, Tenn.
  • 7 updates in biologics

    A spine biologics company's $100 million investment deal and six more key updates in regenerative medicine in the last two months:
  • Spinal biologics company inks $100M deal, aims to go public

    Houston-based FibroBiologics, a regenerative medicine company developing treatments for chronic disease using fibroblast cells, signed an agreement with a private investment group that will provide the company with up to $100 million over the next three years.

Featured Webinars

Featured Whitepapers

Featured Podcast